Track the CONDUIT PHARMACEUTICALS INC. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €822m. The latest transaction was filed on 13 June 2025 (Attribution). Among the most active insiders: Farley Chele Chiavacci. All data is openly available.
19
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€251,334
3 ops.
Sell Volume
30Σ signal
Buys n/a€251,334 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 75 of 29,063 companies
91.5
score / 100
Value
96
Quality
87
FCF yld44%
Earn yld14%
EV/EBITDA3.9x
ROE20%
Gross mgn·
Net mgn14%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
CONDUIT PHARMACEUTICALS INC. es una empresa dedicada al desarrollo de tratamientos innovadores para enfermedades graves. Cotiza en NASDAQ bajo el ticker XNAS.